Diagnostic morphology: Biophysical indicators for iron-driven inflammatory diseases

Integrative Biology (United Kingdom)

Volumn 6, Issue 5, 2014, Pages 486-510

  Pretorius, Etheresia ^a   Kell, Douglas B ^b  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FIBRIN; FIBRINOGEN; IRON;

ALZHEIMER DISEASE; ANTIPHOSPHOLIPID SYNDROME; BLOOD RHEOLOGY; BLOOD VISCOSITY; CEREBROVASCULAR ACCIDENT; COMORBIDITY; DISEASE COURSE; DYSFIBRINOGENEMIA; ERYTHROCYTE; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE SEDIMENTATION RATE; ERYTHROCYTE SHAPE; ERYTHROCYTE STRUCTURE; FIBRIN CLOT; HEMATOCRIT; HEMOCHROMATOSIS; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; LUPUS ERYTHEMATOSUS; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERIZATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; RHEUMATIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84899053093     PISSN: 17579694     EISSN: 17579708     Source Type: Journal    
DOI: 10.1039/c4ib00025k     Document Type: Review

References (392)

1. WHO, Global status report on noncommunicable diseases, Geneva, 2011
2. J. P. Després B. J. Arsenault M. Côté A. Cartier I. Lemieux Abdominal obesity: the cholesterol of the 21st century? Can. J. Cardiol. 2008 24 Suppl D 7D 12D
3. C. Ballantyne B. Arroll J. Shepherd Lipids and CVD management: towards a global consensus Eur. Heart J. 2005 26 2224 2231 (Pubitemid 41541384)
4. A. Neylon C. Canniffe S. Anand C. Kreatsoulas G. J. Blake D. Sugrue C. McGorrian A global perspective on psychosocial risk factors for cardiovascular disease Prog. Cardiovasc. Dis. 2013 55 574 581
5. B. Norrving B. Kissela The global burden of stroke and need for a continuum of care Neurology 2013 80 S5 S12
6. S. van de Vijver S. Oti J. Addo A. de Graft-Aikins C. Agyemang Review of community-based interventions for prevention of cardiovascular diseases in low- and middle-income countries Ethn. Health 2012 17 651 676
7. D. Pitocco M. Tesauro R. Alessandro G. Ghirlanda C. Cardillo Oxidative stress in diabetes: implications for vascular and other complications Int. J. Mol. Sci. 2013 14 21525 21550
8. G. H. Kim J. J. Ryan S. L. Archer The role of redox signaling in epigenetics and cardiovascular disease Antioxid. Redox Signaling 2013 18 1920 1936
9. A. Bachi I. Dalle-Donne A. Scaloni Redox proteomics: chemical principles, methodological approaches and biological/biomedical promises Chem. Rev. 2013 113 596 698
10. F. Bonomini S. Tengattini A. Fabiano R. Bianchi R. Rezzani Atherosclerosis and oxidative stress Histol. Histopathol. 2008 23 381 390
11. D. Giustarini I. Dalle-Donne D. Tsikas R. Rossi Oxidative stress and human diseases: origin, link, measurement, mechanisms, and biomarkers Crit. Rev. Clin. Lab. Sci. 2009 46 241 281
12. K. Jomova S. Baros M. Valko Redox active metal-induced oxidative stress in biological systems. Transition Met. Chem. 2012 37 127 134
13. P. I. Moreira A. I. Duarte M. S. Santos A. C. Rego C. R. Oliveira An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease J. Alzheimer's Dis. 2009 16 741 761
14. A. Nunomura R. J. Castellani X. Zhu P. I. Moreira G. Perry M. A. Smith Involvement of oxidative stress in Alzheimer disease J. Neuropathol. Exp. Neurol. 2006 65 631 641 (Pubitemid 44297254)
15. S. Orrenius V. Gogvadze B. Zhivotovsky Mitochondrial oxidative stress: implications for cell death Annu. Rev. Pharmacol. Toxicol. 2007 47 143 183
16. A. Skoumalová J. Hort Blood markers of oxidative stress in Alzheimer's disease J. Cell. Mol. Med. 2012 16 2291 2300
17. N. A. Strobel R. G. Fassett S. A. Marsh J. S. Coombes Oxidative stress biomarkers as predictors of cardiovascular disease Int. J. Cardiol. 2011 147 191 201
18. R. M. Touyz Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 2004 44 248 252 (Pubitemid 39167216)
19. G. Vitale S. Salvioli C. Franceschi Oxidative stress and the ageing endocrine system Nat. Rev. Endocrinol. 2013 9 228 240
20. C. Webb D. Twedt Oxidative stress and liver disease Vet. Clin. North Am. Small Anim. Pract. 2008 38 125 135 (Pubitemid 351176588)
21. Y. H. Wei H. C. Lee Oxidative stress, mitochondrial DNA mutation, and impairment of antioxidant enzymes in aging Exp. Biol. Med. 2002 227 671 682
22. X. Zhu B. Su X. Wang M. A. Smith G. Perry Causes of oxidative stress in Alzheimer disease Cell. Mol. Life Sci. 2007 64 2202 2210 (Pubitemid 47347959)
23. H. Koyama Y. Nishizawa AGEs/RAGE in CKD: irreversible metabolic memory road toward CVD? Eur. J. Clin. Invest. 2010 40 623 635
24. M. S. Karbiner L. Sierra C. Minahk M. C. Fonio M. P. Bruno S. Jerez The role of oxidative stress in alterations of hematological parameters and inflammatory markers induced by early hypercholesterolemia Life Sci. 2013 93 503 508
25. J. Zacho A. Tybjaerg-Hansen J. S. Jensen P. Grande H. Sillesen B. G. Nordestgaard Genetically elevated C-reactive protein and ischemic vascular disease N. Engl. J. Med. 2008 359 1897 1908
26. M. Thomsen T. S. Ingebrigtsen J. L. Marott M. Dahl P. Lange J. Vestbo B. G. Nordestgaard Inflammatory Biomarkers and Exacerbations in Chronic Obstructive Pulmonary Disease JAMA, J. Am. Med. Assoc. 2013 309 2353 2361
27. K. Mochizuki R. Miyauchi Y. Misaki N. Kasezawa K. Tohyama T. Goda Associations between leukocyte counts and cardiovascular disease risk factors in apparently healthy Japanese men J. Nutr. Sci. Vitaminol. 2012 58 181 186
28. B. Uttara A. V. Singh P. Zamboni R. T. Mahajan Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options Curr. Neuropharmacol. 2009 7 65 74
29. B. Halliwell and J. M. C. Gutteridge, Free Radicals Biol. Med., Oxford University Press, Oxford, 4th edn, 2006
30. M. Cortez-Cooper E. Meaders J. Stallings S. Haddow B. Kraj G. Sloan K. K. McCully J. G. Cannon Soluble TNF and IL-6 receptors: indicators of vascular health in women without cardiovascular disease Vasc. Med. 2013 18 282 289
31. I. Jialal B. A. Huet H. Kaur A. Chien S. Devaraj Increased toll-like receptor activity in patients with metabolic syndrome Diabetes Care 2012 35 900 904
32. B. T. Baune M. Rothermundt K. H. Ladwig C. Meisinger K. Berger Systemic inflammation (Interleukin 6) predicts all-cause mortality in men: results from a 9-year follow-up of the MEMO Study Age 2011 33 209 217
33. P. Syrovatka P. Kraml J. Potockova L. Fialova M. Vejrazka J. Crkovska M. Andel Relationship between increased body iron stores, oxidative stress and insulin resistance in healthy men Ann. Nutr. Metab. 2009 54 268 274
34. W. Wang M. A. Knovich L. G. Coffman F. M. Torti S. V. Torti Serum ferritin: Past, present and future Biochim. Biophys. Acta 2010 1800 760 769
35. J. G. Wilson J. H. Lindquist S. C. Grambow E. D. Crook J. F. Maher Potential role of increased iron stores in diabetes Am. J. Med. Sci. 2003 325 332 339 (Pubitemid 36712655)
36. M. Zegrean Association of body iron stores with development of cardiovascular disease in the adult population: a systematic review of the literature Can. J. Cardiovasc. Nurs. 2009 19 26 32
37. A. Wilks G. Heinzl Heme oxygenation and the widening paradigm of heme degradation Arch. Biochem. Biophys. 2014 544 87 95
38. Z. A. Khan Y. P. Barbin M. Cukiernik P. C. Adams S. Chakrabarti Heme-oxygenase-mediated iron accumulation in the liver Can. J. Physiol. Pharmacol. 2004 82 448 456 (Pubitemid 39388384)
39. M. E. Conrad J. N. Umbreit Iron absorption and transport-an update Am. J. Hematol. 2000 64 287 298
40. V. G. Nielsen E. C. Pearson M. C. Smith Increased carbon monoxide production by hemeoxygenase-1 caused by device-mediated hemolysis: thrombotic phantom menace? Artif. Organs 2013 37 1008 1014
41. W. Bao F. Song X. Li S. Rong W. Yang M. Zhang P. Yao L. Hao N. Yang F. B. Hu L. Liu Plasma heme oxygenase-1 concentration is elevated in individuals with type 2 diabetes mellitus PLoS One 2010 5 e12371
42. A. Takahashi M. Mori T. Naruto S. Nakajima T. Miyamae T. Imagawa S. Yokota The role of heme oxygenase-1 in systemic-onset juvenile idiopathic arthritis Mod. Rheumatol. 2009 19 302 308
43. D. T. Redford J. L. Thompson J. C. McCulloch V. G. Nielsen Left atrial myxoma presenting as pulmonary embolism: potential role of heme oxygenase-1 Blood Coagulation Fibrinolysis 2014
44. E. Daugas C. Cande G. Kroemer Erythrocytes: death of a mummy Cell Death Differ. 2001 8 1131 1133 (Pubitemid 34048467)
45. A. Lupescu R. Bissinger K. Jilani F. Lang Triggering of suicidal erythrocyte death by celecoxib Toxins 2013 5 1543 1554
46. G. Minetti S. Egee D. Morsdorf P. Steffen A. Makhro C. Achilli A. Ciana J. Wang G. Bouyer I. Bernhardt C. Wagner S. Thomas A. Bogdanova L. Kaestner Red cell investigations: art and artefacts Blood Rev. 2013 27 91 101
47. T. D. AlMomani S. C. Vigmostad V. K. Chivukula L. Al-zube O. Smadi S. BaniHani Red blood cell flow in the cardiovascular system: a fluid dynamics perspective Crit. Rev. Biomed. Eng. 2012 40 427 440
48. Y. I. Cho D. J. Cho Hemorheology and microvascular disorders Korean Circ. J. 2011 41 287 295
49. J. Danesh R. Collins R. Peto G. D. Lowe Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease Eur. Heart J. 2000 21 515 520 (Pubitemid 30148316)
50. J. Tripette T. Alexy M. D. Hardy-Dessources D. Mougenel E. Beltan T. Chalabi R. Chout M. Etienne-Julan O. Hue H. J. Meiselman P. Connes Red blood cell aggregation, aggregate strength and oxygen transport potential of blood are abnormal in both homozygous sickle cell anemia and sickle-hemoglobin C disease Haematologica 2009 94 1060 1065
51. M. W. Rampling H. J. Meiselman B. Neu O. K. Baskurt Influence of cell-specific factors on red blood cell aggregation Biorheology 2004 41 91 112 (Pubitemid 38526708)
52. G. Reggiori G. Occhipinti A. De Gasperi J. L. Vincent M. Piagnerelli Early alterations of red blood cell rheology in critically ill patients Crit. Care Med. 2009 37 3041 3046
53. S. K. Ballas N. Mohandas Sickle red cell microrheology and sickle blood rheology Microcirculation 2004 11 209 225 (Pubitemid 39619080)
54. B. C. Lechtenberg S. M. Freund J. A. Huntington An ensemble view of thrombin allostery Biol. Chem. 2012 393 889 898
55. A. S. Wolberg A. E. Mast Tissue factor and factor VIIa-hemostasis and beyond Thromb. Res. 2012 129 suppl 2 S1 S4
56. A. Undas R. A. S. Ariëns Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases Arterioscler., Thromb., Vasc. Biol. 2011 31 e88 e99
57. R. A. Campbell K. A. Overmyer C. H. Selzman B. C. Sheridan A. S. Wolberg Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability Blood 2009 114 4886 4896
58. S. A. Smith The cell-based model of coagulation J. Vet. Emerg. Crit. Care 2009 19 3 10
59. A. K. Vine Recent advances in haemostasis and thrombosis Retina 2009 29 1 7
60. V. G. Nielsen Beyond cell based models of coagulation: analyses of coagulation with clot "lifespan" resistance-time relationships Thromb. Res. 2008 122 145 152 (Pubitemid 351756506)
61. G. Romney M. Glick An updated concept of coagulation with clinical implications J. Am. Dent. Assoc. 2009 140 567 574
62. H. R. Roberts M. Hoffman D. M. Monroe A cell-based model of thrombin generation Semin. Thromb. Hemostasis 2006 32 suppl 1 32 38
63. E. F. Grabowski K. Yam M. Gerace Evaluation of hemostasis in flowing blood Am. J. Hematol. 2012 87 suppl 1 S51 S55
64. P. G. Gallagher Disorders of red cell volume regulation Curr. Opin. Hematol. 2013 20 201 207
65. J. P. Lopes de Almeida S. Oliveira C. Saldanha Erythrocyte as a biological sensor Clin. Hemorheol. Microcirc. 2012 51 1 20
66. M. J. Telen Red blood cell surface adhesion molecules: their possible roles in normal human physiology and disease Semin. Hematol. 2000 37 130 142 (Pubitemid 30211152)
67. P. S. Walmet J. R. Eckman T. M. Wick Inflammatory mediators promote strong sickle cell adherence to endothelium under venular flow conditions Am. J. Hematol. 2003 73 215 224 (Pubitemid 36898876)
68. M. Montagnana G. Cervellin T. Meschi G. Lippi The role of red blood cell distribution width in cardiovascular and thrombotic disorders Clin. Chem. Lab. Med. 2012 50 635 641
69. P. Kowal Hemorheology in cerebral ischemia Neurol. Neurochir. Pol. 1996 30 suppl 2 7 11
70. J. G. Mohanty D. M. Eckley J. D. Williamson L. J. Launer J. M. Rifkind Do red blood cell-beta-amyloid interactions alter oxygen delivery in Alzheimer's disease? Adv. Exp. Med. Biol. 2008 614 29 35
71. E. Nagy J. W. Eaton V. Jeney M. P. Soares Z. Varga Z. Galajda J. Szentmiklosi G. Mehes T. Csonka A. Smith G. M. Vercellotti G. Balla J. Balla Red cells, hemoglobin, heme, iron, and atherogenesis Arterioscler. Thromb. Vasc. Biol. 2010 30 1347 1353
72. E. Pretorius B. Lipinski Thromboembolic ischemic stroke changes red blood cell morphology Cardiovasc. Pathol. 2013 22 241 242
73. S. Shin Y. Ku N. Babu M. Singh Erythrocyte deformability and its variation in diabetes mellitus Indian J. Exp. Biol. 2007 45 121 128
74. M. N. Starodubtseva T. G. Kuznetsova N. I. Yegorenkov S. N. Cherenkevich Structural and mechanical characteristics of erythrocyte membranes in patients with type 2 diabetes mellitus Bull. Exp. Biol. Med. 2008 145 99 103
75. A. Steinvil S. Berliner I. Shapira O. Rogowski D. Justo J. George A. Halkin G. Keren A. Finkelstein S. Banai Y. Arbel Time to rheology in acute myocardial infarction: inflammation and erythrocyte aggregation as a consequence and not necessarily as precursors of the disease Clin. Res. Cardiol. 2010 99 651 656
76. A. C. Swanepoel E. Pretorius Scanning electron microscopy analysis of erythrocytes in thromboembolic ischemic stroke Int. J. Lab. Hematol. 2012 34 185 191
77. G. Erikssen K. Liestol J. V. Bjornholt H. Stormorken E. Thaulow J. Erikssen Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease mortality Eur. Heart J. 2000 21 1614 1620
78. S. Gangopadhyay V. K. Vijayan S. K. Bansal Lipids of erythrocyte membranes of COPD patients: a quantitative and qualitative study COPD 2012 9 322 331
79. M. Madjid O. Fatemi Components of the complete blood count as risk predictors for coronary heart disease: in-depth review and update Tex. Heart Inst. J. 2013 40 17 29
80. M. Straat R. van Bruggen D. de Korte N. P. Juffermans Red blood cell clearance in inflammation Transfus. Med. Hemother. 2012 39 353 361
81. D. B. Kell Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases BMC Med. Genomics 2009 2 2
82. D. B. Kell Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples Arch. Toxicol. 2010 84 825 889
83. C. Funke S. A. Schneider D. Berg D. B. Kell Genetics and iron in the systems biology of Parkinson's disease and some related disorders Neurochem. Int. 2013 62 637 652
84. B. Wong Points of view: the overview figure Nat. Methods 2011 8 365
85. O. K. Baskurt H. J. Meiselman Erythrocyte aggregation: basic aspects and clinical importance Clin. Hemorheol. Microcirc. 2013 53 23 37
86. D. G. Yanbaeva M. A. Dentener E. C. Creutzberg G. Wesseling E. F. Wouters Systemic effects of smoking Chest 2007 131 1557 1566 (Pubitemid 46762366)
87. C. G. Spencer D. C. Felmeden A. D. Blann G. Y. Lip Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial J. Intern. Med. 2007 261 82 90 (Pubitemid 46046475)
88. D. R. Gagnon T. J. Zhang F. N. Brand W. B. Kannel Hematocrit and the risk of cardiovascular disease-the Framingham study: a 34-year follow-up Am. Heart J. 1994 127 674 682 (Pubitemid 24124700)
89. P. T. Skretteberg J. Bodegård S. E. Kjeldsen G. Erikssen E. Thaulow L. Sandvik J. E. Erikssen Interaction between inflammation and blood viscosity predicts cardiovascular mortality Scand. Cardiovasc. J. 2010 44 107 112
90. B. S. Bull W. C. Levy J. C. Westengard M. Farr P. F. Smith J. F. Apperley P. A. Bacon J. Stuart Ranking of laboratory tests by consensus analysis Lancet 1986 2 377 380 (Pubitemid 16036508)
91. L. J. Tamariz J. H. Young J. S. Pankow H. C. Yeh M. I. Schmidt B. Astor F. L. Brancati Blood viscosity and hematocrit as risk factors for type 2 diabetes mellitus: the atherosclerosis risk in communities (ARIC) study Am. J. Epidemiol. 2008 168 1153 1160
92. S. G. Wannamethee I. J. Perry A. G. Shaper Hematocrit and risk of NIDDM Diabetes 1996 45 576 579 (Pubitemid 26140540)
93. C. Irace F. Scarinci V. Scorcia D. Bruzzichessi R. Fiorentino G. Randazzo G. Scorcia A. Gnasso Association among low whole blood viscosity, haematocrit, haemoglobin and diabetic retinopathy in subjects with type 2 diabetes Br. J. Ophthalmol. 2011 95 94 98
94. L. Paul P. Jeemon J. Hewitt L. McCallum P. Higgins M. Walters J. McClure J. Dawson P. Meredith G. C. Jones S. Muir A. F. Dominiczak G. Lowe G. T. McInnes S. Padmanabhan Hematocrit predicts long-term mortality in a nonlinear and sex-specific manner in hypertensive adults Hypertension 2012 60 631 638
95. G. Moroni S. Quaglini B. Gallelli G. Banfi P. Messa C. Ponticelli Progressive improvement of patient and renal survival and reduction of morbidity over time in patients with lupus nephritis (LN) followed for 20 years Lupus 2013 22 810 818
96. B. Satirapoj J. Wongchinsri N. Youngprang B. Laonapaporn T. Chitrada S. Lapkittichareonchai J. Patumanon Predictors of renal involvement in patients with systemic lupus erythematosus Asian Pac. J. Allergy Immunol. 2007 25 17 25 (Pubitemid 46971149)
97. A. Lanas J. L. Goldstein F. K. Chan C. M. Wilcox D. A. Peura C. Li G. H. Sands J. M. Scheiman Risk factors associated with a decrease >/= 2 g/dL in haemoglobin and/or >/= 10% haematocrit in osteoarthritis patients taking celecoxib or a nonselective NSAID plus a PPI in a large randomised controlled trial (CONDOR) Aliment. Pharmacol. Ther. 2012 36 485 492
98. C. Irace C. Carallo F. Scavelli M. S. De Franceschi T. Esposito A. Gnasso Blood viscosity in subjects with normoglycemia and prediabetes Diabetes care 2014 37 488 492 10.2337/dc13-1374
99. D. E. Furst H. Chang J. D. Greenberg V. K. Ranganath G. Reed Z. E. Ozturk J. M. Kremer Prevalence of low hemoglobin levels and associations with other disease parameters in rheumatoid arthritis patients: evidence from the CORRONA registry Clin. Exp. Rheumatol. 2009 27 560 566
100. A. Kamanli M. Naziroǧlu N. Aydilek C. Hacievliyagil Plasma lipid peroxidation and antioxidant levels in patients with rheumatoid arthritis Cell Biochem. Funct. 2004 22 53 57 (Pubitemid 38113621)
101. L. Kellert C. Herweh M. Sykora P. Gussmann E. Martin P. A. Ringleb T. Steiner J. Bosel Loss of Penumbra by Impaired Oxygen Supply? Decreasing Hemoglobin Levels Predict Infarct Growth after Acute Ischemic Stroke: Stroke: Relevant Impact of Hemoglobin, Hematocrit and Transfusion (STRAIGHT)-An Observational Study Cerebrovasc. Dis. Extra 2012 2 99 107
102. L. Eischer V. Tscholl G. Heinze L. Traby P. A. Kyrle S. Eichinger Hematocrit and the risk of recurrent venous thrombosis: a prospective cohort study PLoS One 2012 7 e38705
103. M. J. Simmonds H. J. Meiselman O. K. Baskurt Blood rheology and aging J. Geriatr. Cardiol. 2013 10 291 301
104. N. N. Barvitenko M. Aslam J. Filosa E. Matteucci M. Nikinmaa A. Pantaleo C. Saldanha O. K. Baskurt Tissue oxygen demand in regulation of the behavior of the cells in the vasculature Microcirculation 2013 20 484 501
105. S. Schuster H. Stark What can we learn from Einstein and Arrhenius about the optimal flow of our blood? Biochim. Biophys. Acta 2014 1840 271 276
106. L. N. Toksvang R. M. Berg Using a classic paper by Robin Fahraeus and Torsten Lindqvist to teach basic hemorheology Adv. Physiol. Educ. 2013 37 129 133
107. O. K. Baskurt H. J. Meiselman Blood rheology and hemodynamics Semin. Thromb. Hemostasis 2003 29 435 450 (Pubitemid 37352643)
108. O. K. Baskurt O. Yalcin H. J. Meiselman Hemorheology and vascular control mechanisms Clin. Hemorheol. Microcirc. 2004 30 169 178 (Pubitemid 38951501)
109. M. L. Bassett Haemochromatosis: iron still matters Intern. Med. J. 2001 31 237 242 (Pubitemid 32592651)
110. H. J. Meiselman B. Neu M. W. Rampling O. K. Baskurt RBC aggregation: laboratory data and models Indian J. Exp. Biol. 2007 45 9 17
111. A. Miller M. Green D. Robinson Simple rule for calculating normal erythrocyte sedimentation rate Br. Med. J. 1983 286 266 (Pubitemid 13149367)
112. C. J. McMahon S. Hopkins A. Vail A. T. King D. Smith K. J. Illingworth S. Clark N. J. Rothwell P. J. Tyrrell Inflammation as a predictor for delayed cerebral ischemia after aneurysmal subarachnoid haemorrhage J. Neurointerv. Surg. 2013 5 512 517
113. M. L. Brigden Clinical utility of the erythrocyte sedimentation rate Am. Fam. Physician 1999 60 1443 1450 (Pubitemid 29498209)
114. J. Bathon J. Graves P. Jens R. Hamrick M. Mayes The erythrocyte sedimentation rate in end-stage renal failure Am. J. Kidney Dis 1987 10 34 40
115. M. B. Andresdottir N. Sigfusson H. Sigvaldason V. Gudnason Erythrocyte sedimentation rate, an independent predictor of coronary heart disease in men and women: The Reykjavik Study Am. J. Epidemiol. 2003 158 844 851 (Pubitemid 37323246)
116. T. Skogh D. Gustafsson M. Kjellberg M. Husberg Twenty eight joint count disease activity score in recent onset rheumatoid arthritis using C reactive protein instead of erythrocyte sedimentation rate Ann. Rheum. Dis. 2003 62 681 682 (Pubitemid 36760572)
117. R. Skalak P. R. Zarda K. M. Jan S. Chien Mechanics of Rouleau formation Biophys. J. 1981 35 771 781 (Pubitemid 11053389)
118. H. Beving L. E. Eriksson C. L. Davey D. B. Kell Dielectric properties of human blood and erythrocytes at radio frequencies (0.2-10 MHz); dependence on cell volume fraction and medium composition Eur. Biophys. J. 1994 23 207 215 (Pubitemid 24275238)
119. M. Musielak J. Koscielak Different RBC aggregating properties of the Aalpha2Bbeta2gammaA2 and Aalpha2Bbeta2gammaAgamma' subpopulations of human fibrinogen Clin. Hemorheol. Microcirc. 2006 35 301 303
120. R. Ben Ami G. Barshtein D. Zeltser Y. Goldberg I. Shapira A. Roth G. Keren H. Miller V. Prochorov A. Eldor S. Berliner S. Yedgar Parameters of red blood cell aggregation as correlates of the inflammatory state Am. J. Physiol.: Heart Circ. Physiol. 2001 280 H1982 H1988
121. C. J. Schlimp H. Schöchl The role of fibrinogen in trauma-induced coagulopathy Hamostaseologie 2014 34 29 39 10.5482/HAMO-13-07-0038
122. M. A. Meyer S. R. Ostrowski N. A. Windelov P. I. Johansson Fibrinogen concentrates for bleeding trauma patients: what is the evidence? Vox Sang. 2011 101 185 190
123. D. Fries W. Z. Martini Role of fibrinogen in trauma-induced coagulopathy Br. J. Anaesth. 2010 105 116 121
124. M. Pavlovic D. Babic P. Rastovic I. Ljevak Association of erythrocyte sedimentation rate and fibrinogen concentration with metabolic syndrome in schizophrenic patients Psychiatr. Danubina 2013 25 suppl 1 51 55
125. O. N. Baskurt, B. Neu and H. J. Meiselman, Red Blood Cell Aggregation, CRC Press, Boca Raton, 2011
126. G. Késmárky P. Kenyeres M. Késmárky K. Tóth Plasma viscosity: a forgotten variable Clin. Hemorheol. Microcirc. 2008 39 243 246 (Pubitemid 352040003)
127. O. K. Baskurt H. J. Meiselman Iatrogenic hyperviscosity and thrombosis Semin. Thromb. Hemostasis 2012 38 854 864
128. D. Cairncross G. M. Collins G. Kostalas J. Ludbrook Blood viscosity and erythrocyte sedimentation rate in patients with thrombotic arterial disorders Med. J. Aust. 1969 1 1348 1352
129. C. Y. Chang H. J. Liang S. Y. Chow S. M. Chen D. Z. Liu Hemorheological mechanisms in Alzheimer's disease Microcirculation 2007 14 627 634
130. S. S. Pollock M. J. Harrison Red cell deformability is not an independent risk factor in stroke J. Neurol., Neurosurg. Psychiatry 1982 45 369 371 (Pubitemid 12150156)
131. I. A. Tikhomirova A. O. Oslyakova S. G. Mikhailova Microcirculation and blood rheology in patients with cerebrovascular disorders Clin. Hemorheol. Microcirc. 2011 49 295 305
132. R. M. Johnson Y. Ravindranath M. S. ElAlfy G. Goyette, Jr. Oxidant damage to erythrocyte membrane in glucose-6, phosphate, dehydrogenase, deficiency: correlation with in vivo reduced glutathione concentration and membrane protein oxidation Blood 1994 83 1117 1123 (Pubitemid 24058563)
133. M. Ju S. S. Ye H. T. Low J. Zhang P. Cabrales H. L. Leo S. Kim Effect of deformability difference between two erythrocytes on their aggregation Phys. Biol. 2013 10 036001
134. Y. Kim, K. Kim and K. Park, Measurement Techniques for Red Blood Cell Deformability: Recent Advances, in Blood Cell-An Overview of Studies in Hematology, InTech, 2012, pp. 167-195
135. M. Lekka M. Fornal G. Pyka-Fosciak K. Lebed B. Wizner T. Grodzicki J. Styczen Erythrocyte stiffness probed using atomic force microscope Biorheology 2005 42 307 317 (Pubitemid 41437654)
136. N. Mohandas J. A. Chasis Red blood cell deformability, membrane material properties and shape: regulation by transmembrane, skeletal and cytosolic proteins and lipids Semin. Hematol. 1993 30 171 192 (Pubitemid 23216313)
137. I. Sokolov M. E. Dokukin N. V. Guz Method for quantitative measurements of the elastic modulus of biological cells in AFM indentation experiments Methods 2013 60 202 213
138. Z. Zhou C. Zheng S. Li X. Zhou Z. Liu Q. He N. Zhang A. Ngan B. Tang A. Wang AFM nanoindentation detection of the elastic modulus of tongue squamous carcinoma cells with different metastatic potentials Nanomedicine 2013 9 864 874
139. Y. W. Chiou H. K. Lin M. J. Tang H. H. Lin M. L. Yeh The influence of physical and physiological cues on atomic force microscopy-based cell stiffness assessment PLoS One 2013 8 e77384
140. J. Bester A. V. Buys B. Lipinski D. B. Kell E. Pretorius High ferritin levels have major effects on the morphology of erythrocytes in Alzheimer's disease. Front. Aging Neurosci. 2013 5 88 10.3389/fnagi.2013.00088
141. B. Derjaguin V. Muller Y. Toporov Effect of contact deformations on the adhesion of particles. J. Colloid Interface Sci. 1975 53 314 326
142. S. Park Y. J. Lee Nano-mechanical compliance of Muller cells investigated by atomic force microscopy Int. J. Biol. Sci. 2013 9 702 706
143. M. E. Dokukin N. V. Guz I. Sokolov Quantitative study of the elastic modulus of loosely attached cells in AFM indentation experiments Biophys. J. 2013 104 2123 2131
144. B. Lipinski E. Pretorius H. M. Oberholzer W. J. van der Spuy Interaction of fibrin with red blood cells: the role of iron Ultrastruct. Pathol. 2012 36 79 84
145. E. Pretorius J. Bester N. Vermeulen B. Lipinski G. S. Gericke D. B. Kell Profound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and other agents PLoS One 2014 9 e85271 10.1371/journal.pone. 0085271
146. E. Pretorius J. du Plooy P. Soma A. Y. Gasparyan An ultrastructural analysis of platelets, erythrocytes, white blood cells, and fibrin network in systemic lupus erythematosus Rheumatol. Int. 2013
147. E. Pretorius B. Lipinski Iron alters red blood cell morphology Blood 2013 121 9
148. P. de Moerloose F. Boehlen M. Neerman-Arbez Fibrinogen and the risk of thrombosis Semin. Thromb. Hemostasis 2010 36 7 17
149. A. Undas Acquired dysfibrinogenemia in atherosclerotic vascular disease Pol. Arch. Med. Wewn. 2011 121 310 319
150. N. Muradashvili D. Lominadze Role of fibrinogen in cerebrovascular dysfunction after traumatic brain injury Brain Inj. 2013 27 1508 1515 10.3109/02699052.2013.823562
151. R. A. Adams C. Schachtrup D. Davalos I. Tsigelny K. Akassoglou Fibrinogen signal transduction as a mediator and therapeutic target in inflammation: lessons from multiple sclerosis Curr. Med. Chem. 2007 14 2925 2936 (Pubitemid 350201659)
152. N. Azad L. Agrawal N. V. Emanuele R. Klein G. D. Bahn M. McCarren P. Reaven R. Hayward W. Duckworth Association of PAI-1 and Fibrinogen with Diabetic Retinopathy in the Veterans Affairs Diabetes Trial (VADT) Diabetes Care 2014 37 501 506 10.2337/dc13-1193
153. A. Bini B. J. Kudryk Fibrinogen and fibrin in the arterial wall Thromb. Res. 1994 75 337 341 (Pubitemid 24241967)
154. M. Cortes-Canteli J. Paul E. H. Norris R. Bronstein H. J. Ahn D. Zamolodchikov S. Bhuvanendran K. M. Fenz S. Strickland Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease Neuron 2010 66 695 709
155. D. Dávalos K. Akassoglou Fibrinogen as a key regulator of inflammation in disease Semin. Immunopathol. 2012 34 43 62
156. M. Kostapanos M. Florentin M. S. Elisaf D. P. Mikhailidis Hemostatic Factors and the Metabolic Syndrome Curr. Vasc. Pharmacol. 2013 11 880 905
157. B. Hoppe T. Dörner Coagulation and the fibrin network in rheumatic disease: a role beyond haemostasis Nat. Rev. Rheumatol. 2012 8 738 746
158. G. Lippi C. Mattiuzzi E. J. Favaloro Novel and emerging therapies: thrombus-targeted fibrinolysis Semin. Thromb. Hemostasis 2013 39 48 58
159. R. A. Ariëns Elevated fibrinogen causes thrombosis Blood 2011 117 4687 4688
160. R. A. Ariëns Fibrin(ogen) and thrombotic disease J. Thromb. Haemostasis 2013 11 suppl 1 294 305
161. B. Lipinski E. Pretorius H. M. Oberholzer W. J. Van Der Spuy Iron enhances generation of fibrin fibers in human blood: Implications for pathogenesis of stroke Microsc. Res. Tech. 2012 75 1185 1190
162. E. Rooth N. H. Wallen M. Blomback S. He Decreased fibrin network permeability and impaired fibrinolysis in the acute and convalescent phase of ischemic stroke Thromb. Res. 2011 127 51 56
163. R. A. Ajjan T. Gamlen K. F. Standeven S. Mughal K. Hess K. A. Smith E. J. Dunn M. M. Anwar N. Rabbani P. J. Thornalley H. Philippou P. J. Grant Diabetes is associated with posttranslational modifications in plasminogen resulting in reduced plasmin generation and enzyme-specific activity Blood 2013 122 134 142
164. M. Cucuianu M. Coca Thrombotic tendency in diabetes mellitus. Revisiting and revising a study initiated 30 years ago Rom. J. Intern. Med. 2012 50 107 115
165. I. O. Blokhin S. R. Lentz Mechanisms of thrombosis in obesity Curr. Opin. Hematol. 2013 20 437 444
166. M. Zbczyk J. Majewski J. Lelakowski Thromboembolic events are associated with prolonged clot lysis time in patients with permanent atrial fibrillation Pol. Arch. Med. Wewn. 2011 121 400 407
167. B. Lipinski E. Pretorius Novel pathway of ironinduced blood coagulation: implications for diabetes mellitus and its complications Pol. Arch. Med. Wewn. 2012 122 115 122
168. R. Lassila Role and management of coagulation disorders in peripheral arterial disease Scand. J. Surg. 2012 101 94 99
169. E. L. Grove S. Gregersen Antiplatelet therapy in patients with diabetes mellitus Curr. Vasc. Pharmacol. 2012 10 494 505
170. G. J. Brewer Iron and copper toxicity in diseases of aging, particularly atherosclerosis and Alzheimer's disease Exp. Biol. Med. 2007 232 323 335 (Pubitemid 46203301)
171. X. Chen T. O. Scholl T. P. Stein Association of elevated serum ferritin levels and the risk of gestational diabetes mellitus in pregnant women: The Camden study Diabetes Care 2006 29 1077 1082 (Pubitemid 44115247)
172. A. Gupta A. Watkins P. Thomas R. Majer N. Habubi G. Morris K. Pansari Coagulation and inflammatory markers in Alzheimer's and vascular dementia Int. J. Clin. Pract. 2005 59 52 57 (Pubitemid 40260114)
173. M. Y. Chan F. Andreotti R. C. Becker Hypercoagulable states in cardiovascular disease Circulation 2008 118 2286 2297
174. J. B. Duguid Thrombosis as a factor in the pathogenesis of coronary atherosclerosis J. Pathol. Bacteriol. 1946 58 207 212
175. E. B. Smith Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis Clin. Haematol. 1986 15 355 370 (Pubitemid 16028876)
176. D. A. Lomas D. A. Lipson B. E. Miller L. Willits O. Keene H. Barnacle N. C. Barnes R. Tal-Singer An oral inhibitor of p38 MAP kinase reduces plasma fibrinogen in patients with chronic obstructive pulmonary disease J. Clin. Pharmacol. 2012 52 416 424
177. W. MacNee R. J. Allan I. Jones M. C. De Salvo L. F. Tan Efficacy and safety of the oral p38 inhibitor PH-797804 in chronic obstructive pulmonary disease: a randomised clinical trial Thorax 2013 68 738 745
178. D. Zamolodchikov S. Strickland Abeta delays fibrin clot lysis by altering fibrin structure and attenuating plasminogen binding to fibrin Blood 2012 119 3342 3351
179. H. J. Ahn D. Zamolodchikov M. Cortes-Canteli E. H. Norris J. F. Glickman S. Strickland Alzheimer's disease peptide beta-amyloid interacts with fibrinogen and induces its oligomerization Proc. Natl. Acad. Sci. U. S. A. 2010 107 21812 21817
180. E. Pretorius N. Vermeulen J. Bester Atypical erythrocytes and platelets in a patient with a pro-thrombin mutation Platelets 2013
181. A. Undas P. Kaczmarek K. Sladek E. Stpień W. Skucha M. Rzeszutko I. Gorkiewicz-Kot W. Tracz Fibrin clot properties are altered in patients with chronic obstructive pulmonary disease. Beneficial effects of simvastatin treatment Thromb. Haemostasis 2009 102 1176 1182
182. M. Pieters R. C. Kotze J. C. Jerling A. Kruger R. A. Ariëns Evidence that fibrinogen gamma' regulates plasma clot structure and lysis and relationship to cardiovascular risk factors in black Africans Blood 2013 121 3254 3260
183. J. P. Collet Y. Allali C. Lesty M. L. Tanguy J. Silvain A. Ankri B. Blanchet R. Dumaine J. Gianetti L. Payot J. W. Weisel G. Montalescot Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis Arterioscler. Thromb. Vasc. Biol. 2006 26 2567 2573 (Pubitemid 44607482)
184. A. V. Buys M. J. Van Rooy P. Soma D. Van Papendorp B. Lipinski E. Pretorius Changes in red blood cell membrane structure in type 2 diabetes: a scanning electron and atomic force microscopy study Cardiovasc. Diabetol. 2013 12 25
185. E. Pretorius H. M. Oberholzer W. J. van der Spuy A. C. Swanepoel P. Soma Qualitative scanning electron microscopy analysis of fibrin networks and platelet abnormalities in diabetes Blood Coagulation Fibrinolysis 2011 22 463 467
186. E. Pretorius B. Lipinski J. Bester N. Vermeulen P. Soma Albumin stabilizes fibrin fiber ultrastructure in low serum albumin type 2 diabetes Ultrastruct. Pathol. 2013 37 254 257
187. M. Bochenek J. Zalewski J. Sadowski A. Undas Type 2 diabetes as a modifier of fibrin clot properties in patients with coronary artery disease J. Thromb. Thrombolysis 2013 35 264 270
188. E. J. Dunn H. Philippou R. A. Ariëns P. J. Grant Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus Diabetologia 2006 49 1071 1080
189. P. K. Dhillon M. J. Adams Thrombosis in systemic lupus erythematosus: role of impaired fibrinolysis Semin. Thromb. Hemostasis 2013 39 434 440
190. A. Y. Gasparyan L. Ayvazyan E. Pretorius G. D. Kitas Platelets in Rheumatic Diseases: Friend or Foe? Curr. Pharm. Des. 2013
191. E. Pretorius H. M. Oberholzer W. J. van der Spuy A. C. Swanepoel P. Soma Scanning electron microscopy of fibrin networks in rheumatoid arthritis: a qualitative analysis Rheumatol. Int. 2012 32 1611 1615
192. B. Kwasny-Krochin P. Gluszko A. Undas Unfavorably altered fibrin clot properties in patients with active rheumatoid arthritis Thromb. Res. 2010 126 e11 e16
193. J. J. Marsh P. G. Chiles N. C. Liang T. A. Morris Chronic thromboembolic pulmonary hypertension-associated dysfibrinogenemias exhibit disorganized fibrin structure Thromb. Res. 2013 132 729 734 10.1016/j.thromres.2013.09.024
194. B. Lipinski E. Pretorius Hydroxyl radical-modified fibrinogen as a marker of thrombosis: the role of iron Hematology 2012 17 241 247
195. B. Lipinski E. Pretorius Iron-induced fibrin in cardiovascular disease Curr. Neurovasc. Res. 2013 10 269 274
196. E. Pretorius Quantifying changes in fibrin fiber network morphology Ultrastruct. Pathol. 2011 35 150 154
197. A. Undas A. Slowik P. Wolkow A. Szczudlik W. Tracz Fibrin clot properties in acute ischemic stroke: relation to neurological deficit Thromb. Res. 2010 125 357 361
198. A. Undas P. Podolec K. Zawilska M. Pieculewicz I. Jedliński E. Stepień E. Konarska-Kuszewska P. Weglarz M. Duszyńska E. Hanschke T. Przewlocki W. Tracz Altered fibrin clot structure/function in patients with cryptogenic ischemic stroke Stroke 2009 40 1499 1501
199. M. Stalc M. Tomsic M. K. Jezovnik P. Poredos Endothelium-dependent and independent dilation capability of peripheral arteries in patients with systemic lupus erythematosus and antiphospholipid syndrome Clin. Exp. Rheumatol. 2011 29 616 623
200. P. R. Ames L. Iannaccone J. D. Alves A. Margarita L. R. Lopez V. Brancaccio Factor XIII in primary antiphospholipid syndrome J. Rheumatol. 2005 32 1058 1062 (Pubitemid 40828079)
201. P. de Pablo A. Ramirez E. Cortina A. de la Pena J. Zamora R. Izaguirre M. C. Amigo Increased fibrin polymerization rate in patients with primary antiphospholipid syndrome and systemic lupus erythematosus Clin. Appl. Thromb./Hemostasis 2003 9 221 225 (Pubitemid 37070130)
202. P. R. Ames J. Alves A. F. Pap P. Ramos M. A. Khamashta G. R. Hughes Fibrinogen in systemic lupus erythematosus: more than an acute phase reactant? J. Rheumatol. 2000 27 1190 1195 (Pubitemid 30262503)
203. M. van Oijen J. C. Witteman A. Hofman P. J. Koudstaal M. M. Breteler Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia Stroke 2005 36 2637 2641
204. N. Papageorgiou D. Tousoulis A. Miliou G. Hatzis M. Kozanitou E. Androulakis M. Charakida A. Antonopoulos C. Antoniades A. Briasoulis A. Giolis G. Bouras Z. Pallantza C. Stefanadis Combined effects of fibrinogen genetic variability on atherosclerosis in patients with or without stable angina pectoris: Focus on the coagulation cascade and endothelial function Int. J. Cardiol. 2013 168 4602 4607
205. K. Oszajca K. Wronski G. Janiszewska M. Bienkiewicz M. Panek J. Bartkowiak J. Szemraj Association analysis of genetic polymorphisms of factor V, factor VII and fibrinogen beta chain genes with human abdominal aortic aneurysm Exp. Ther. Med. 2012 4 514 518
206. P. M. Ridker C. P. Howard V. Walter B. Everett P. Libby J. Hensen T. Thuren Effects of interleukin-1beta inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial Circulation 2012 126 2739 2748
207. J. Kolodziejczyk M. B. Ponczek The role of fibrinogen, fibrin and fibrin(ogen) degradation products (FDPs) in tumor progression Contemp. Oncol. 2013 17 113 119
208. A. T. Toriola J. A. Laukkanen S. Kurl K. Nyyssonen K. Ronkainen J. Kauhanen Prediagnostic circulating markers of inflammation and risk of prostate cancer Int. J. Cancer 2013 133 2961 2967
209. L. Sheng M. Luo X. Sun N. Lin W. Mao D. Su Serum fibrinogen is an independent prognostic factor in operable nonsmall cell lung cancer Int. J. Cancer 2013 133 2720 2725
210. T. Yoneyama S. Ohtsuki M. Ono K. Ohmine Y. Uchida T. Yamada M. Tachikawa T. Terasaki Quantitative targeted absolute proteomics-based large-scale quantification of proline-hydroxylated alpha-fibrinogen in plasma for pancreatic cancer diagnosis J. Proteome Res. 2013 12 753 762
211. A. Agustí L. D. Edwards S. I. Rennard W. MacNee R. Tal-Singer B. E. Miller J. Vestbo D. A. Lomas P. M. Calverley E. Wouters C. Crim J. C. Yates E. K. Silverman H. O. Coxson P. Bakke R. J. Mayer B. Celli Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype PLoS One 2012 7 e37483
212. P. J. Barnes B. R. Celli Systemic manifestations and comorbidities of COPD Eur. Respir. J. 2009 33 1165 1185
213. M. Dahl A. Tybjærg-Hansen J. Vestbo P. Lange B. G. Nordestgaard Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 2001 164 1008 1011 (Pubitemid 32971649)
214. G. C. Donaldson T. A. Seemungal I. S. Patel A. Bhowmik T. M. Wilkinson J. R. Hurst P. K. Maccallum J. A. Wedzicha Airway and systemic inflammation and decline in lung function in patients with COPD Chest 2005 128 1995 2004 (Pubitemid 41507533)
215. A. Duvoix J. Dickens I. Haq D. Mannino B. Miller R. Tal-Singer D. A. Lomas Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease Thorax 2013 68 670 676
216. W. Q. Gan S. F. P. Man A. Senthilselvan D. D. Sin Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis Thorax 2004 59 574 580 (Pubitemid 38901515)
217. F. Garcia-Rio M. Miravitlles J. B. Soriano L. Muñoz E. Duran-Tauleria G. Sánchez V. Sobradillo J. Ancochea Systemic inflammation in chronic obstructive pulmonary disease: a population-based study Respir. Res. 2010 11 63
218. K. H. Groenewegen D. S. Postma W. C. Hop P. L. Wielders N. J. Schlosser E. F. Wouters Increased systemic inflammation is a risk factor for COPD exacerbations Chest 2008 133 350 357 (Pubitemid 351272391)
219. B. Lazovic Correlation of CRP and serum level of fibrinogen with severity of disease in chronic obstructive pulmonary disease patients Med. Arh. 2012 66 159 160
220. D. M. Mannino D. Valvi H. Mullerova R. Tal-Singer Fibrinogen, COPD and mortality in a nationally representative U.S. cohort COPD 2012 9 359 366
221. B. L. Nicholas Search for biomarkers in chronic obstructive pulmonary disease: current status Curr. Opin. Pulm. Med. 2013 19 103 108
222. E. Pizzichini M. M. Pizzichini P. Gibson K. Parameswaran G. J. Gleich L. Berman J. Dolovich F. E. Hargreave Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis Am. J. Respir. Crit. Care Med. 1998 158 1511 1517
223. M. Polatli A. Cakir O. Cildag A. Z. Bolaman C. Yenisey Y. Yenicerioglu Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation J. Thromb. Thrombolysis 2008 26 97 102
224. T. Seemungal R. Harper-Owen A. Bhowmik I. Moric G. Sanderson S. Message P. Maccallum T. W. Meade D. J. Jeffries S. L. Johnston J. A. Wedzicha Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 2001 164 1618 1623 (Pubitemid 33124148)
225. Y. Shibata S. Abe S. Inoue A. Igarashi K. Yamauchi Y. Aida H. Kishi K. Nunomiya H. Nakano M. Sato K. Sato T. Kimura T. Nemoto T. Watanabe T. Konta Y. Ueno T. Kato T. Kayama I. Kubota Relationship between plasma fibrinogen levels and pulmonary function in the Japanese population: the Takahata study Int. J. Med. Sci. 2013 10 1530 1536
226. D. D. Sin S. F. P. Man Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease Circulation 2003 107 1514 1519 (Pubitemid 36378490)
227. N. J. Sinden R. A. Stockley Systemic inflammation and comorbidity in COPD: a result of 'overspill' of inflammatory mediators from the lungs? Review of the evidence Thorax 2010 65 930 936
228. B. Thyagarajan D. R. Jacobs G. G. Apostol L. J. Smith C. E. Lewis O. D. Williams Plasma fibrinogen and lung function: the CARDIA Study Int. J. Epidemiol. 2006 35 1001 1008 (Pubitemid 44540754)
229. D. Valvi D. M. Mannino H. Mullerova R. Tal-Singer Fibrinogen chronic obstructive pulmonary disease (COPD) and outcomes in two United States cohorts Int. J. Chronic Obstruct. Pulm. Dis. 2012 7 173 182
230. J. A. Wedzicha T. A. R. Seemungal P. K. MacCallum E. A. Paul G. C. Donaldson A. Bhowmik D. J. Jeffries T. W. Meade Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels Thromb. Haemostasis 2000 84 210 215 (Pubitemid 30601465)
231. O. Morel L. Jesel M. Abbas N. Morel Prothrombotic Changes in Diabetes Mellitus Semin. Thromb. Hemostasis 2013 39 477 488 10.1055/s-0033-1343888
232. P. Gyawali R. S. Richards E. Uba Nwose Erythrocyte morphology in metabolic syndrome Expert Rev. Hematol. 2012 5 523 531
233. X. Zhang S. C. McGeoch A. M. Johnstone G. Holtrop A. A. Sneddon S. M. Macrury I. L. Megson D. W. Pearson P. Abraham B. De Roos G. E. Lobley N. O'Kennedy Platelet-derived microparticle count and surface molecule expression differ between subjects with and without type 2 diabetes, independently of obesity status J. Thromb. Thrombolysis 2013
234. T. M. Okwuosa O. Klein C. Chan N. S. Jenny P. Schreiner D. Green K. Liu 13-year long-term associations between changes in traditional cardiovascular risk factors and changes in fibrinogen levels: the Coronary Artery Risk Development in Young Adults (CARDIA) study Atherosclerosis 2013 226 214 219
235. A. N. Kul S. Ozdemir A. Helvaci C. Bulut S. Dursun The Relationship of Acute Myocardial Infarction With or Without ST-Segment Elevation and Viscosity Clin. Appl. Thromb./Hemostasis 2013
236. O. Akgul H. Uyarel H. Pusuroglu M. Gul N. Isiksacan S. Turen M. Erturk O. Surgit M. Cetin U. Bulut O. F. Baycan N. Uslu Predictive value of elevated D-dimer in patients undergoing primary angioplasty for ST elevation myocardial infarction Blood Coagulation Fibrinolysis 2013 24 704 710
237. R. Kaiser Y. Li M. Chang J. Catanese A. B. Begovich E. E. Brown J. C. Edberg G. McGwin, Jr. G. S. Alarcon R. Ramsey-Goldman J. D. Reveille L. M. Vila M. A. Petri R. P. Kimberly K. E. Taylor L. A. Criswell Genetic risk factors for thrombosis in systemic lupus erythematosus J. Rheumatol. 2012 39 1603 1610
238. G. Lippi E. J. Favaloro M. Franchini Paradoxical thrombosis part 1: factor replacement therapy, inherited clotting factor deficiencies and prolonged APTT J. Thromb. Thrombolysis 2012 34 360 366
239. A. Vayá J. Calvo C. Alcalá L. Micó J. Todolí J. M. Ricart Rheological alterations and thrombotic events in patients with systemic lupus erythematosus Clin. Hemorheol. Microcirc. 2012 51 51 58
240. A. Vayá J. Murado M. Santaolaria M. Simo L. Mico J. Calvo J. Todolí J. M. Ricart Haemorheological changes in patients with systemic lupus erythematosus do not seem to be related to thrombotic events Clin. Hemorheol. Microcirc. 2008 38 23 29 (Pubitemid 350256698)
241. E. Corrado M. Rizzo G. Caccamo G. Coppola I. Muratori R. Tantillo S. Dell'oglio C. Nugara F. Macaione G. Novo R. Alcamo A. Mignano F. Ferrara S. Novo Prevalence of metabolic syndrome: a comparative analysis in an unselected sample of mediterranean subjects Int. Angiol. 2012 31 572 578
242. M. Maksimović H. Vlajinac D. Radak J. Marinković J. Maksimović J. Jorga Relationship between abdominal obesity and other cardiovascular risk factors: cross sectional study of patients with symptomatic carotid disease Srp. Arh. Celok. Lek. 2013 141 460 465
243. G. G. Korkmaz E. Altinoglu S. Civelek V. Sozer F. Erdenen O. Tabak H. Uzun The association of oxidative stress markers with conventional risk factors in the metabolic syndrome Metab., Clin. Exp. 2013 62 828 835
244. B. E. Gilliam M. R. Reed A. K. Chauhan A. B. Dehlendorf T. L. Moore Evidence of fibrinogen as a target of citrullination in IgM rheumatoid factor-positive polyarticular juvenile idiopathic arthritis Pediatr. Rheumatol. Online J. 2011 9 8
245. F. Lv L. J. Song X. F. Li Combined measurement of multiple acute phase reactants to predict relapse of rheumatoid arthritis Int. J. Rheum. Dis. 2013 10.1111/1756-185X.12186
246. K. Shin S. Hong E. H. Choi M. K. Lim S. C. Shim J. H. Ju S. H. Lee Role of citrullinated fibrinogen peptides in the activation of CD4 T cells from patients with rheumatoid arthritis Immune Netw. 2013 13 116 122
247. W. B. Kannel P. A. Wolf W. P. Castelli R. B. D'Agostino Fibrinogen and risk of cardiovascular disease. The Framingham Study JAMA, J. Am. Med. Assoc. 1987 258 1183 1186
248. J. Zhang L. Yu Y. Yin Q. Lu L. Lei J. Xiao J. Guo J. Zhao Y. Wang G. He Y. Xu L. He Association between two functional fibrinogen-related polymorphisms and ischemic stroke: a case-control study Genet. Test. Mol. Biomarkers 2013 17 789 793
249. A. Lasek-Bal P. Puz Z. Kazibutowska Elevated factor VIII level and stroke in patients without traditional risk factors associated with cardiovascular diseases Neuropsychiatr. Dis. Treat. 2013 9 847 852
250. E. Pretorius H. Steyn M. Engelbrecht A. C. Swanepoel H. M. Oberholzer Differences in fibrin fiber diameters in healthy individuals and thromboembolic ischemic stroke patients Blood Coagulation Fibrinolysis 2011 22 696 700
251. E. Pretorius B. Lipinski Differences in Morphology of Fibrin Clots Induced with Thrombin and Ferric Ions and Its Pathophysiological Consequences Heart, Lung Circ. 2012 22 447 449
252. A. Undas K. Szuldrzynski E. Stepien J. Zalewski J. Godlewski W. Tracz M. Pasowicz K. Zmudka Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: effects of inflammation and oxidative stress Atherosclerosis 2008 196 551 557
253. P. Allan S. Uitte de Willige R. H. Abou-Saleh S. D. Connell R. A. Ariëns Evidence that fibrinogen gamma' directly interferes with protofibril growth: implications for fibrin structure and clot stiffness J. Thromb. Haemostasis 2012 10 1072 1080
254. J. R. Houser N. E. Hudson L. Ping E. T. O'Brien, 3rd R. Superfine S. T. Lord M. R. Falvo Evidence that alphaC region is origin of low modulus, high extensibility, and strain stiffening in fibrin fibers Biophys. J. 2010 99 3038 3047
255. L. Medved S. Litvinovich T. Ugarova Y. Matsuka K. Ingham Domain structure and functional activity of the recombinant human fibrinogen gamma-module (gamma148-411) Biochemistry 1997 36 4685 4693 (Pubitemid 27180319)
256. J. P. Collet J. L. Moen Y. I. Veklich O. V. Gorkun S. T. Lord G. Montalescot J. W. Weisel The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis Blood 2005 106 3824 3830 (Pubitemid 41739019)
257. L. Medved J. W. Weisel Recommendations for nomenclature on fibrinogen and fibrin J. Thromb. Haemostasis 2009 7 355 359
258. E. A. Ryan L. F. Mockros J. W. Weisel L. Lorand Structural origins of fibrin clot rheology Biophys. J. 1999 77 2813 2826 (Pubitemid 29519524)
259. E. Pretorius S. Briedenhann J. Marx R. C. Franz Structural changes in the fibrin network of a pretoria family with dysfibrinogenemia: a scanning electron microscopical study Ultrastruct. Pathol. 2006 30 167 176 (Pubitemid 44049771)
260. M. Matsuda T. Sugo Hereditary disorders of fibrinogen Ann. N. Y. Acad. Sci. 2001 936 65 88 (Pubitemid 32613893)
261. Z. Yang I. Mochalkin R. F. Doolittle A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides Proc. Natl. Acad. Sci. U. S. A. 2000 97 14156 14161 (Pubitemid 32016546)
262. R. S. Lovely L. A. Falls H. A. Al-Mondhiry C. E. Chambers G. J. Sexton H. Ni D. H. Farrell Association of gammaA/gamma' fibrinogen levels and coronary artery disease Thromb. Haemostasis 2002 88 26 31 (Pubitemid 34752262)
263. E. Y. Cheung S. Uitte de Willige H. L. Vos F. W. Leebeek D. W. Dippel R. M. Bertina M. P. de Maat Fibrinogen gamma' in ischemic stroke: a case-control study Stroke 2008 39 1033 1035 (Pubitemid 351619556)
264. I. Parastatidis L. Thomson A. Burke I. Chernysh C. Nagaswami J. Visser S. Stamer D. C. Liebler G. Koliakos H. F. Heijnen G. A. Fitzgerald J. W. Weisel H. Ischiropoulos Fibrinogen beta-chain tyrosine nitration is a prothrombotic risk factor J. Biol. Chem. 2008 283 33846 33853
265. C. Vadseth J. M. Souza L. Thomson A. Seagraves C. Nagaswami T. Scheiner J. Torbet G. Vilaire J. S. Bennett J. C. Murciano V. Muzykantov M. S. Penn S. L. Hazen J. W. Weisel H. Ischiropoulos Pro-thrombotic state induced by post-translational modification of fibrinogen by reactive nitrogen species J. Biol. Chem. 2004 8820 8828
266. M. Piagnerelli K. Zouaoui Boudjeltia D. Brohee A. Vereerstraeten P. Piro J. L. Vincent M. Vanhaeverbeek Assessment of erythrocyte shape by flow cytometry techniques J. Clin. Pathol. 2007 60 549 554 (Pubitemid 46867168)
267. M. Piagnerelli F. Cotton M. Van Nuffelen J. L. Vincent B. Gulbis Modifications in erythrocyte membrane protein content are not responsible for the alterations in rheology seen in sepsis Shock 2012 37 17 21
268. A. P. DeFilippis K. Law S. Curtin J. R. Eckman Blood is thicker than water: the management of hyperviscosity in adults with cyanotic heart disease Cardiol. Rev. 2007 15 31 34 (Pubitemid 46005946)
269. D. Pulanic I. Rudan The past decade: fibrinogen Coll. Antropol. 2005 29 341 349 (Pubitemid 40978290)
270. P. M. Moriarty C. A. Gibson Association between hematological parameters and high-density lipoprotein cholesterol Curr. Opin. Cardiol. 2005 20 318 323 (Pubitemid 40896372)
271. G. D. Sloop D. E. Mercante Opposite effects of low-density and high-density lipoprotein on blood viscosity in fasting subjects Clin. Hemorheol. Microcirc. 1998 19 197 203 (Pubitemid 28549651)
272. R. B. Ami G. Barshtein D. Zeltser Y. Goldberg I. Shapira A. Roth G. Keren H. Miller V. Prochorov A. Eldor S. Berliner S. Yedgar Parameters of red blood cell aggregation as correlates of the inflammatory state Am. J. Physiol.: Heart Circ. Physiol. 2001 280 H1982 H1988
273. D. Justo N. Mashav Y. Arbel M. Kinori A. Steinvil M. Swartzon B. Molat A. Halkin A. Finkelstein R. Heruti S. Banai Increased erythrocyte aggregation in men with coronary artery disease and erectile dysfunction Int. J. Impotence Res. 2009 21 192 197
274. N. Bolokadze I. Lobjanidze N. Momtselidze R. Shakarishvili G. McHedlishvili Comparison of erythrocyte aggregability changes during ischemic and hemorrhagic stroke Clin. Hemorheol. Microcirc. 2006 35 265 267 (Pubitemid 44126512)
275. M. A. Elblbesy A. R. Hereba M. M. Shawki Effects of aspirin on rheological properties of erythrocytes in vitro Int. J. Biomed. Sci. 2012 8 188 193
276. A. G. Atici S. Kayhan D. Aydin Y. A. Yilmaz Plasma viscosity levels in pulmonary thromboembolism Clin. Hemorheol. Microcirc. 2013 55 313 320 10.3233/CH-2012-1637
277. F. Bajd J. Vidmar A. Blinc I. Sersa Analysis of blood clot degradation fragment sizes in relation to plasma flow velocity Gen. Physiol. Biophys. 2012 31 237 245
278. R. Holsworth, Jr. Y. Cho J. J. Weidman G. Sloop J. St Cyr Cardiovascular benefits of phlebotomy: relationship to changes in hemorheological variables Perfusion 2014 29 102 116 10.1177/0267659113505637
279. A. Somani M. E. Steiner R. P. Hebbel The dynamic regulation of microcirculatory conduit function: features relevant to transfusion medicine Transfus. Apher. Sci. 2010 43 61 68
280. R. M. Olinescu F. A. Kummerow Fibrinogen is an efficient antioxidant J. Nutr. Biochem. 2001 12 162 169 (Pubitemid 32197490)
281. Y. H. Feng G. Hart In vitro oxidative damage to tissue-type plasminogen activator: a selective modification of the biological functions Cardiovasc. Res. 1995 30 255 261
282. G. R. Upchurch Jr N. Ramdev M. T. Walsh J. Loscalzo Prothrombotic Consequences of the Oxidation of Fibrinogen and their Inhibition by Aspirin J. Thromb. Thrombolysis 1998 5 9 14 (Pubitemid 28075248)
283. P. Kanwar K. V. Kowdley Diagnosis and treatment of hereditary hemochromatosis: an update Expert Rev. Gastroenterol. Hepatol. 2013 7 517 530
284. J. K. Limdi J. R. Crampton Hereditary haemochromatosis QJM 2004 97 315 324 (Pubitemid 38807410)
285. S. Lynch G. Soslau Iron levels found in hemochromatosis patients inhibit gamma-thrombin-induced platelet aggregation Platelets 2012 23 611 616
286. G. D. McLaren V. R. Gordeuk Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study Hematology Am. Soc. Hematol. Educ. Program 2009 195 206
287. P. Nielsen U. Günther M. Dürken R. Fischer J. Düllmann Serum ferritin iron in iron overload and liver damage: correlation to body iron stores and diagnostic relevance J. Lab. Clin. Med. 2000 135 413 418
288. J. Waalen V. J. Felitti T. Gelbart E. Beutler Screening for hemochromatosis by measuring ferritin levels: a more effective approach Blood 2008 111 3373 3376
289. G. Zandman-Goddard Y. Shoenfeld Hyperferritinemia in autoimmunity Isr. Med. Assoc. J. 2008 10 83 84 (Pubitemid 351649475)
290. P. Adams Management of elevated serum ferritin levels Gastroenterol. Hepatol. 2008 4 333 334 (Pubitemid 351768986)
291. N. Ahluwalia A. Genoux J. Ferrieres B. Perret M. Carayol L. Drouet J. B. Ruidavets Iron status is associated with carotid atherosclerotic plaques in middle-aged adults J. Nutr. 2010 140 812 816
292. R. G. Depalma V. W. Hayes B. K. Chow G. Shamayeva P. E. May L. R. Zacharski Ferritin levels, inflammatory biomarkers, and mortality in peripheral arterial disease: a substudy of the Iron (Fe) and Atherosclerosis Study (FeAST) Trial J. Vasc. Surg. 2010 51 1498 1503
293. K. Goot S. Hazeldine P. Bentley J. Olynyk D. Crawford Elevated serum ferritin-what should GPs know? Aust. Fam. Physician 2012 41 945 949
294. L. Sun O. H. Franco F. B. Hu L. Cai Z. Yu H. Li X. Ye Q. Qi J. Wang A. Pan Y. Liu X. Lin Ferritin concentrations, metabolic syndrome, and type, 2, diabetes in middle-aged and elderly chinese J. Clin. Endocrinol. Metab. 2008 93 4690 4696
295. K. Jomova M. Valko Advances in metal-induced oxidative stress and human disease Toxicology 2011 283 65 87
296. K. Jomova D. Vondrakova M. Lawson M. Valko Metals, oxidative stress and neurodegenerative disorders Mol. Cell. Biochem. 2010 345 91 104
297. E. Pretorius N. Vermeulen J. Bester B. Lipinski D. B. Kell A novel method for assessing the role of iron and its functional chelation in fibrin fibril formation: the use of scanning electron microscopy Toxicol. Mech. Methods 2013 23 352 359
298. I. Dulińska M. Targosz W. Strojny M. Lekka P. Czuba W. Balwierz M. Szymoński Stiffness of normal and pathological erythrocytes studied by means of atomic force microscopy J. Biochem. Biophys. Methods 2006 66 1 11 (Pubitemid 43254623)
299. J. Dupire M. Socol A. Viallat Full dynamics of a red blood cell in shear flow Proc. Natl. Acad. Sci. U. S. A. 2012 109 20808 20813
300. M. P. Sheetz R. G. Painter S. J. Singer Biological membranes as bilayer couples. III. Compensatory shape changes induced in membranes J. Cell Biol. 1976 70 193 203
301. O. K. Baskurt H. J. Meiselman Comparative hemorheology Clin. Hemorheol. Microcirc. 2013 53 61 70
302. J. Delaunay The molecular basis of hereditary red cell membrane disorders Blood Rev. 2007 21 1 20 (Pubitemid 46110925)
303. A. G. Moutzouri A. T. Skoutelis C. A. Gogos Y. F. Missirlis G. M. Athanassiou Red blood cell deformability in patients with sepsis: a marker for prognosis and monitoring of severity Clin. Hemorheol. Microcirc. 2007 36 291 299 (Pubitemid 46868439)
304. V. Bennett J. Healy Membrane domains based on ankyrin and spectrin associated with cell-cell interactions Cold Spring Harbor Perspect. Biol. 2009 1 a003012
305. E. K. Kozlova A. M. Chernysh V. V. Moroz A. N. Kuzovlev Analysis of nanostructure of red blood cells membranes by space Fourier transform of AFM images Micron 2013 44 218 227 10.1016/j.micron.2012.06.012
306. M. Girasole S. Dinarelli G. Boumis Structure and function in native and pathological erythrocytes: a quantitative view from the nanoscale Micron 2012 43 1273 1286
307. E. van den Akker T. J. Satchwell R. C. Williamson A. M. Toye Band 3 multiprotein complexes in the red cell membrane; of mice and men Blood Cells, Mol., Dis. 2010 45 1 8
308. A. J. Baines P. M. Bennett E. W. Carter C. Terracciano Protein 4.1 and the control of ion channels Blood Cells, Mol., Dis. 2009 42 211 215
309. A. Czogalla A. F. Sikorski Do we already know how spectrin attracts ankyrin? Cell. Mol. Life Sci. 2010 67 2679 2683
310. S. R. Cunha P. J. Mohler Ankyrin protein networks in membrane formation and stabilization J. Cell. Mol. Med. 2009 13 4364 4376
311. N. Uyesaka S. Hasegawa N. Ishioka R. Ishioka H. Shio A. N. Schechter Effects of superoxide anions on red cell deformability and membrane proteins Biorheology 1992 29 217 229
312. J. P. Lopes de Almeida T. Freitas-Santos C. Saldanha Erythrocyte deformability dependence on band 3 protein in an in-vitro model of hyperfibrinogenemia Clin. Hemorheol. Microcirc. 2012 50 213 219
313. M. Girasole G. Pompeo A. Cricenti A. Congiu-Castellano F. Andreola A. Serafino B. H. Frazer G. Boumis G. Amiconi Roughness of the plasma membrane as an independent morphological parameter to study RBCs: a quantitative atomic force microscopy investigation Biochim. Biophys. Acta 2007 1768 1268 1276 (Pubitemid 46550350)
314. V. V. Moroz A. M. Chernysh E. K. Kozlova P. Y. Borshegovskaya U. A. Bliznjuk R. M. Rysaeva O. Y. Gudkova Comparison of red blood cell membrane microstructure after different physicochemical influences: atomic force microscope research J. Crit. Care 2010 25 539
315. E. Bennett-Guerrero T. H. Veldman A. Doctor M. J. Telen T. L. Ortel T. S. Reid M. A. Mulherin H. Zhu R. D. Buck R. M. Califf T. J. McMahon Evolution of adverse changes in stored RBCs Proc. Natl. Acad. Sci. U. S. A. 2007 104 17063 17068 (Pubitemid 350210992)
316. E. Pretorius J. N. du Plooy P. Soma I. Keyser A. V. Buys Smoking and fluidity of erythrocyte membranes: A high resolution scanning electron and atomic force microscopy investigation Nitric Oxide 2013 35 42 46
317. A. S. Kamruzzahan F. Kienberger C. M. Stroh J. Berg R. Huss A. Ebner R. Zhu C. Rankl H. J. Gruber P. Hinterdorfer Imaging morphological details and pathological differences of red blood cells using tapping-mode AFM. Biol. Chem. 2004 385 955 956
318. M. Girasole S. Dinarelli G. Boumis Structural, morphological and nanomechanical characterisation of intermediate states in the ageing of erythrocytes J. Mol. Recognit. 2012 25 285 291
319. M. Girasole G. Pompeo A. Cricenti G. Longo G. Boumis A. Bellelli S. Amiconi The how, when, and why of the aging signals appearing on the human erythrocyte membrane: an atomic force microscopy study of surface roughness Nanomedicine 2010 6 760 768
320. A. M. Chernysh E. K. Kozlova V. V. Moroz V. A. Sergunova O. Y. Gudkova M. S. Fedorova Reversible zinc-induced injuries to erythrocyte membrane nanostructure Bull. Exp. Biol. Med. 2012 154 84 88
321. Y. Cui Z. Guo Y. Zhao Y. Zheng Y. Qiao J. Cai S. Liu Reactive effect of low intensity He-Ne laser upon damaged ultrastructure of human erythrocyte membrane in Fenton system by atomic force microscopy Acta Biochim. Biophys. Sin. 2007 39 484 489 (Pubitemid 47117597)
322. V. V. Moroz A. K. Kirsanova I. S. Novodergkina V. V. Alexandrin A. M. Chernysh E. K. Kozlova Macro- and microstructure of erythrocyte membranes under acute massive hemorrhage and subsequent blood reinfusion Semin. Cardiothorac. Vasc. Anesth. 2010 14 248 255
323. M. N. Starodubtseva T. G. Kuznetsova S. A. Chizhik N. I. Yegorenkov Atomic force microscopy observation of peroxynitrite-induced erythrocyte cytoskeleton reorganization Micron 2007 38 782 786 (Pubitemid 47539893)
324. A. H. Swihart J. M. Mikrut J. B. Ketterson R. C. Macdonald Atomic force microscopy of the erythrocyte membrane skeleton J. Microsc. 2001 204 212 225 (Pubitemid 34075119)
325. M. Takeuchi H. Miyamoto Y. Sako H. Komizu A. Kusumi Structure of the erythrocyte membrane skeleton as observed by atomic force microscopy Biophys. J. 1998 74 2171 2183 (Pubitemid 28225214)
326. M. P. Sheetz S. J. Singer Biological membranes as bilayer couples. A molecular mechanism of drug-erythrocyte interactions Proc. Natl. Acad. Sci. U. S. A. 1974 71 4457 4461
327. M. P. Sheetz J. Dai Modulation of membrane dynamics and cell motility by membrane tension Trends Cell Biol. 1996 6 85 89 (Pubitemid 26059740)
328. E. U. Nwose H. F. Jelinek R. S. Richards P. G. Kerr Erythrocyte oxidative stress in clinical management of diabetes and its cardiovascular complications Br. J. Biomed. Sci. 2007 64 35 43 (Pubitemid 46952971)
329. R. T. Acton J. C. Barton L. V. Passmore P. C. Adams M. R. Speechley F. W. Dawkins P. Sholinsky D. M. Reboussin G. D. McLaren E. L. Harris T. C. Bent T. M. Vogt O. Castro Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the Hemochromatosis and Iron Overload Screening (HEIRS) study Diabetes care 2006 29 2084 2089 (Pubitemid 44871191)
330. E. S. Ford M. E. Cogswell Diabetes and serum ferritin concentration among U.S. adults Diabetes care 1999 22 1978 1983 (Pubitemid 30433975)
331. N. G. Forouhi A. H. Harding M. Allison M. S. Sandhu A. Welch R. Luben S. Bingham K. T. Khaw N. J. Wareham Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study Diabetologia 2007 50 949 956 (Pubitemid 46559245)
332. S. N. Rajpathak J. P. Crandall J. Wylie-Rosett G. C. Kabat T. E. Rohan F. B. Hu The role of iron in type 2 diabetes in humans Biochim. Biophys. Acta 2009 1790 671 681
333. D. Galaris K. Pantopoulos Oxidative stress and iron homeostasis: mechanistic and health aspects Crit. Rev. Clin. Lab. Sci. 2008 45 1 23 (Pubitemid 351299652)
334. K. Jomova M. Valko Importance of iron chelation in free radical-induced oxidative stress and human disease Curr. Pharm. Des. 2011 17 3460 3473
335. E. Lang S. M. Qadri F. Lang Killing me softly-suicidal erythrocyte death Int. J. Biochem. Cell Biol. 2012 44 1236 1243
336. M. Singh S. Shin Changes in erythrocyte aggregation and deformability in diabetes mellitus: a brief review Indian J. Exp. Biol. 2009 47 7 15
337. M. Garnier J. R. Attali P. Valensi E. Delatour-Hanss F. Gaudey D. Koutsouris Erythrocyte deformability in diabetes and erythrocyte membrane lipid composition Metab., Clin. Exp. 1990 39 794 798 (Pubitemid 20250990)
338. S. Labrouche G. Freyburger H. Gin M. R. Boisseau C. Cassagne Changes in phospholipid composition of blood cell membranes (erythrocyte, platelet, and polymorphonuclear) in different types of diabetes-clinical and biological correlations Metab., Clin. Exp. 1996 45 57 71
339. M. C. Corti M. Gaziano C. H. Hennekens Iron status and risk of cardiovascular disease Ann. Epidemiol. 1997 7 62 68 (Pubitemid 27082044)
340. A. Dávalos J. M. Fernandez-Real W. Ricart S. Soler A. Molins E. Planas D. Genis Iron-related damage in acute ischemic stroke Stroke 1994 25 1543 1546 (Pubitemid 24233955)
341. A. K. Erdemoglu S. Ozbakir Serum ferritin levels and early prognosis of stroke Eur. J. Neurol. 2002 9 633 637 (Pubitemid 36961290)
342. E. Millerot A. S. Prigent-Tessier N. M. Bertrand P. J. Faure C. M. Mossiat M. E. Giroud A. G. Beley C. Marie Serum ferritin in stroke: a marker of increased body iron stores or stroke severity? J. Cereb. Blood Flow Metab. 2005 25 1386 1393 (Pubitemid 41348740)
343. A. D. van der D. E. Grobbee M. Roest J. J. Marx H. A. Voorbij Y. T. van der Schouw Serum ferritin is a risk factor for stroke in postmenopausal women Stroke 2005 36 1637 1641 (Pubitemid 41098754)
344. K. H. Choi M. S. Park J. T. Kim T. S. Nam S. M. Choi B. C. Kim M. K. Kim K. H. Cho The serum ferritin level is an important predictor of hemorrhagic transformation in acute ischaemic stroke Eur. J. Neurol. 2012 19 570 577
345. T. Reffelmann T. Ittermann M. Dorr H. Volzke M. Reinthaler A. Petersmann S. B. Felix Low serum magnesium concentrations predict cardiovascular and all-cause mortality Atherosclerosis 2011 219 280 284
346. W. R. Markesbery J. M. Carney Oxidative alterations in Alzheimer's disease Brain Pathol. 1999 9 133 146 (Pubitemid 29056524)
347. P. I. Moreira K. Honda Q. Liu M. S. Santos C. R. Oliveira G. Aliev A. Nunomura X. Zhu M. A. Smith G. Perry Oxidative stress: the old enemy in Alzheimer's disease pathophysiology Curr. Alzheimer Res. 2005 2 403 408 (Pubitemid 41277754)
348. A. Nunomura G. Perry G. Aliev K. Hirai A. Takeda E. K. Balraj P. K. Jones H. Ghanbari T. Wataya S. Shimohama S. Chiba C. S. Atwood R. B. Petersen M. A. Smith Oxidative damage is the earliest event in Alzheimer disease J. Neuropathol. Exp. Neurol. 2001 60 759 767 (Pubitemid 32678256)
349. J. C. Kovacic V. Fuster Atherosclerotic risk factors, vascular cognitive impairment, and Alzheimer disease Mt. Sinai J. Med. 2012 79 664 673
350. M. A. Kling J. Q. Trojanowski D. A. Wolk V. M. A. Lee S. E. Arnold Vascular disease and dementias: paradigm shifts to drive research in new directions Alzheimer's Dementia 2013 9 76 92
351. M. Diomedi G. Misaggi Vascular contribution to Alzheimer disease: predictors of rapid progression CNS Neurol. Disord.: Drug Targets 2013 12 532 537
352. M. T. Núñez P. Urrutia N. Mena P. Aguirre V. Tapia J. Salazar Iron toxicity in neurodegeneration 2012 25 761 776
353. W. Y. Ong A. A. Farooqui Iron, neuroinflammation, and Alzheimer's disease J. Alzheimer's Dis. 2005 8 183 200 (Pubitemid 43227164)
354. E. Adeghate T. Donath A. Adem Alzheimer Disease and Diabetes Mellitus: Do They Have Anything In Common? Curr. Alzheimer Res. 2013 10 609 617
355. O. R. Aderibigbe P. T. Pisa R. L. Mamabolo H. S. Kruger H. H. Vorster The relationship between indices of iron status and selected anthropometric cardiovascular disease risk markers in an African population: the THUSA study Cardiovasc. J. Afr. 2011 22 249 256
356. P. A. Adlard A. I. Bush Metals and Alzheimer's disease J. Alzheimer's Dis. 2006 10 145 163 (Pubitemid 44763990)
357. O. A. Azizova A. G. Shvachko A. V. Aseichev Effect of iron ions on functional activity of thrombin Bull. Exp. Biol. Med. 2009 148 776 779
358. K. J. Barnham A. I. Bush Metals in Alzheimer's and Parkinson's diseases Curr. Opin. Chem. Biol. 2008 12 222 228
359. D. Robinson J. Bucci H. Fenn T. Miller J. Tinklenberg J. A. Yesavage Erythrocyte sedimentation rate in Alzheimer's dementia J. Am. Geriatr. Soc. 1995 43 1177 1178
360. N. Tateishi Y. Suzuki I. Cicha N. Maeda O(2) release from erythrocytes flowing in a narrow O(2)-permeable tube: effects of erythrocyte aggregation Am. J. Physiol.: Heart Circ. Physiol. 2001 281 H448 H456
361. D. Tripathy A. Sanchez X. Yin J. Luo J. Martinez P. Grammas Thrombin, a mediator of cerebrovascular inflammation in AD and hypoxia Front. Aging Neurosci. 2013 5 19
362. H. K. Eltzschig P. Carmeliet Hypoxia and inflammation N. Engl. J. Med. 2011 364 656 665
363. T. Wyss-Coray J. Rogers Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature Cold Spring Harbor Perspect. Med. 2012 2 a006346
364. J. G. Mohanty H. D. Shukla J. D. Williamson L. J. Launer S. Saxena J. M. Rifkind Alterations in the red blood cell membrane proteome in alzheimer's subjects reflect disease-related changes and provide insight into altered cell morphology Proteome Sci. 2010 8 11
365. J. Choi C. A. Malakowsky J. M. Talent C. C. Conrad R. W. Gracy Identification of oxidized plasma proteins in Alzheimer's disease Biochem. Biophys. Res. Commun. 2002 293 1566 1570 (Pubitemid 34681057)
366. D. L. Merkle C. H. Cheng F. J. Castellino B. A. Chibber Modulation of fibrin assembly and polymerization by the beta-amyloid of Alzheimer's disease Blood Coagulation Fibrinolysis 1996 7 650 658 (Pubitemid 26370224)
367. J. Paul S. Strickland J. P. Melchor Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease J. Exp. Med. 2007 204 1999 2008 (Pubitemid 47236333)
368. F. Goldblatt S. G. O'Neill Clinical aspects of autoimmune rheumatic diseases Lancet 2013 382 797 808
369. B. Parker I. Bruce SLE and metabolic syndrome Lupus 2013 22 1259 1266
370. N. K. Tyagi R. G. Lahita Therapeutic modalities in systemic lupus erythematosus Saudi Med. J. 2013 34 887 895
371. S. Vilaiyuk N. Sirachainan S. Wanitkun K. Pirojsakul J. Vaewpanich Recurrent macrophage activation syndrome as the primary manifestation in systemic lupus erythematosus and the benefit of serial ferritin measurements: a case-based review Clin. Rheumatol. 2013 32 899 904
372. S. Y. Lee S. W. Lee W. T. Chung Severe inflammation may be caused by hyperferritinemia of pseudo-pseudo Meigs' syndrome in lupus patients: two cases reports and a literature review Clin. Rheumatol. 2013 32 1823 1826
373. G. Zandman-Goddard H. Orbach N. Agmon-Levin M. Boaz H. Amital Z. Szekanecz G. Szucs J. Rovensky E. Kiss N. Corocher A. Doria L. Stojanovich F. Ingegnoli P. L. Meroni B. Rozman J. Gomez-Arbesu M. Blank Y. Shoenfeld Hyperferritinemia is associated with serologic antiphospholipid syndrome in SLE patients Clin. Rev. Allergy Immunol. 2013 44 23 30
374. W. Conca M. Al-Hakim N. Moussa S. Al-Salam P. Corr Hyperferritinemia in a woman with systemic lupus erythematosus, severe nephritis and an iron-rich intraspinal schwannoma mimicking lupus myelopathy Clin. Exp. Rheumatol. 2009 27 834 837
375. C. C. Liu S. Manzi J. M. Ahearn Biomarkers for systemic lupus erythematosus: a review and perspective Curr. Opin. Rheumatol. 2005 17 543 549 (Pubitemid 41527813)
376. G. Murphy L. Lisnevskaia D. Isenberg Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment Lancet 2013 382 809 818
377. M. I. Spengler M. J. Svetaz M. B. Leroux S. M. Bertoluzzo P. Carrara F. Van Isseldyk D. Petrelli F. M. Parente P. Bosch Erythrocyte aggregation in patients with systemic lupus erythematosus Clin. Hemorheol. Microcirc. 2011 47 279 285
378. B. Parker A. Al-Husain P. Pemberton A. P. Yates P. Ho R. Gorodkin L. S. Teh M. Y. Alexander I. N. Bruce Suppression of inflammation reduces endothelial microparticles in active systemic lupus erythematosus Ann. Rheum. Dis. 2013
379. E. Ernst A. Hein M. Meurer T. Ruzicka Blood rheology in lupus erythematosus Ann. Rheum. Dis. 1991 50 710 712
380. M. J. Santos L. M. Pedro H. Canhao E. F. J. Fernandes J. Canas da Silva J. E. Fonseca C. Saldanha Hemorheological parameters are related to subclinical atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis patients Atherosclerosis 2011 219 821 826
381. K. J. Allen L. C. Gurrin C. C. Constantine N. J. Osborne M. B. Delatycki A. J. Nicoll C. E. McLaren M. Bahlo A. E. Nisselle C. D. Vulpe G. J. Anderson M. C. Southey G. G. Giles D. R. English J. L. Hopper J. K. Olynyk L. W. Powell D. M. Gertig Iron-overload-related disease in HFE hereditary hemochromatosis N. Engl. J. Med. 2008 358 221 230
382. P. Clark L. J. Britton L. W. Powell The diagnosis and management of hereditary haemochromatosis Clin. Biochem. Rev. 2010 31 3 8
383. L. C. Gurrin N. J. Osborne C. C. Constantine C. E. McLaren D. R. English D. M. Gertig M. B. Delatycki M. C. Southey J. L. Hopper G. G. Giles G. J. Anderson J. K. Olynyk L. W. Powell K. J. Allen The natural history of serum iron indices for HFE C282Y homozygosity associated with hereditary hemochromatosis Gastroenterology 2008 135 1945 1952
384. V. R. Akoev S. P. Shcherbinina A. V. Matveev S. Tarakhovskii Iu A. A. Deev V. L. Shnyrov Study of structural transitions in erythrocyte membranes during hereditary hemochromatosis Biull. Eksp. Biol. Med. 1997 123 279 284
385. J. C. Barton L. F. Bertoli B. E. Rothenberg Peripheral blood erythrocyte parameters in hemochromatosis: evidence for increased erythrocyte hemoglobin content J. Lab. Clin. Med. 2000 135 96 104 (Pubitemid 30042159)
386. R. E. Fleming R. S. Britton A. Waheed W. S. Sly B. R. Bacon Pathophysiology of hereditary hemochromatosis Semin. Liver Dis. 2005 25 411 419 (Pubitemid 41741258)
387. D. Prá S. I. Franke J. A. Henriques M. Fenech Iron and genome stability: an update Mutat. Res. 2012 733 92 99
388. F. Ezquer M. T. Núñez A. Rojas J. Asenjo Y. Israel Hereditary hemochromatosis: an opportunity for gene therapy Biol. Res. 2006 39 113 124 (Pubitemid 44027653)
389. D. B. Kell Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening and knowledge of transporters: where drug discovery went wrong and how to fix it FEBS J. 2013 280 23 5957 5980 10.1111/febs.12268
390. F. L. Li-Saw-Hee A. D. Blann G. Y. Lip Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation Stroke 2000 31 828 833 (Pubitemid 30198423)
391. J. Vekasi K. Koltai V. Gaal A. Toth I. Juricskay G. Kesmarky The effect of aspirin on hemorheological parameters of patients with diabetic retinopathy Clin. Hemorheol. Microcirc. 2008 39 385 389 (Pubitemid 352040021)
392. B. Lipinski E. Pretorius The Role of Iron-Induced Fibrin in the Pathogenesis of Alzheimer's Disease and the Protective Role of Magnesium Front. Hum. Neurosci. 2013 7 735